Antihypertension induced by tanshinone IIA isolated from the roots of salvia miltiorrhiza

Juei Tang Cheng, Paul Chan, I. Min Liu, Ying Xiao Li, Wen Jen Yu

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Tanshinone IIA is one of the active principles in danshen (Salvia miltiorrhiza Bge) widely used in treatment of cardiovascular disorders. We investigated the effect of danshen or tanshinone IIA on blood pressure and its possible mechanisms. An i.p. injection of danshen at 10mgkg(1) significantly lowered systolic blood pressure (SBP) of spontaneously hypertensive rats (SHRs) but failed to modify the SBP in normotensive Wistar-Kyoto rats (WKY). Oral administration of tanshinone IIA also decreased SBP in SHR but not in WKY. Tanshinone IIA produced a concentration-dependent relaxation in isolated SHR aortic rings precontracted with phenylephrine (10nmol l-1) or potassium chloride (KCl) (40mmoll-1). The relaxing effect of tanshinone IIA on tonic contraction of phenylephrine in isolated aortic rings without endothelium remained produced. Glibenclamide at concentration sufficient to block adenosine triphosphatase (ATP)-sensitive potassium (K+) channel attenuated this tanshinone IIA-induced relaxation that was not influenced by other inhibitors. We further investigated the effect of tanshinone IIA on the changes of intracellular calcium concentration ([Ca2+] i) in cultured aortic smooth muscle (A7r5) cells using fura-2 as indicator. Tanshinone IIA decreased [Ca2+] i elicited by phenylephrine (10nmoll(1)) or KCl (40mmoll(1)) in a concentration-dependent manner; glibenclamide, but not other inhibitors for K+ channel, abated this effect. Our results suggest that tanshinone IIA acts as an active principle of danshen showing vasodilation through ATP-sensitive K+ channel to lower [Ca2+i.

Original languageEnglish
Article number392627
JournalEvidence-based Complementary and Alternative Medicine
Volume2011
DOIs
Publication statusPublished - 2011

Fingerprint

Salvia miltiorrhiza
Blood Pressure
Phenylephrine
Inbred SHR Rats
Inbred WKY Rats
Glyburide
Adenosine Triphosphatases
tanshinone
Potassium Chloride
Fura-2
Potassium Channels
Vasodilation
Smooth Muscle Myocytes
Endothelium
Oral Administration
Calcium

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

Antihypertension induced by tanshinone IIA isolated from the roots of salvia miltiorrhiza. / Cheng, Juei Tang; Chan, Paul; Liu, I. Min; Li, Ying Xiao; Yu, Wen Jen.

In: Evidence-based Complementary and Alternative Medicine, Vol. 2011, 392627, 2011.

Research output: Contribution to journalArticle

@article{10b96c1787e54a1ea8e1dfb92ff8b85e,
title = "Antihypertension induced by tanshinone IIA isolated from the roots of salvia miltiorrhiza",
abstract = "Tanshinone IIA is one of the active principles in danshen (Salvia miltiorrhiza Bge) widely used in treatment of cardiovascular disorders. We investigated the effect of danshen or tanshinone IIA on blood pressure and its possible mechanisms. An i.p. injection of danshen at 10mgkg(1) significantly lowered systolic blood pressure (SBP) of spontaneously hypertensive rats (SHRs) but failed to modify the SBP in normotensive Wistar-Kyoto rats (WKY). Oral administration of tanshinone IIA also decreased SBP in SHR but not in WKY. Tanshinone IIA produced a concentration-dependent relaxation in isolated SHR aortic rings precontracted with phenylephrine (10nmol l-1) or potassium chloride (KCl) (40mmoll-1). The relaxing effect of tanshinone IIA on tonic contraction of phenylephrine in isolated aortic rings without endothelium remained produced. Glibenclamide at concentration sufficient to block adenosine triphosphatase (ATP)-sensitive potassium (K+) channel attenuated this tanshinone IIA-induced relaxation that was not influenced by other inhibitors. We further investigated the effect of tanshinone IIA on the changes of intracellular calcium concentration ([Ca2+] i) in cultured aortic smooth muscle (A7r5) cells using fura-2 as indicator. Tanshinone IIA decreased [Ca2+] i elicited by phenylephrine (10nmoll(1)) or KCl (40mmoll(1)) in a concentration-dependent manner; glibenclamide, but not other inhibitors for K+ channel, abated this effect. Our results suggest that tanshinone IIA acts as an active principle of danshen showing vasodilation through ATP-sensitive K+ channel to lower [Ca2+i.",
author = "Cheng, {Juei Tang} and Paul Chan and Liu, {I. Min} and Li, {Ying Xiao} and Yu, {Wen Jen}",
year = "2011",
doi = "10.1093/ecam/nep056",
language = "English",
volume = "2011",
journal = "Evidence-based Complementary and Alternative Medicine",
issn = "1741-427X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Antihypertension induced by tanshinone IIA isolated from the roots of salvia miltiorrhiza

AU - Cheng, Juei Tang

AU - Chan, Paul

AU - Liu, I. Min

AU - Li, Ying Xiao

AU - Yu, Wen Jen

PY - 2011

Y1 - 2011

N2 - Tanshinone IIA is one of the active principles in danshen (Salvia miltiorrhiza Bge) widely used in treatment of cardiovascular disorders. We investigated the effect of danshen or tanshinone IIA on blood pressure and its possible mechanisms. An i.p. injection of danshen at 10mgkg(1) significantly lowered systolic blood pressure (SBP) of spontaneously hypertensive rats (SHRs) but failed to modify the SBP in normotensive Wistar-Kyoto rats (WKY). Oral administration of tanshinone IIA also decreased SBP in SHR but not in WKY. Tanshinone IIA produced a concentration-dependent relaxation in isolated SHR aortic rings precontracted with phenylephrine (10nmol l-1) or potassium chloride (KCl) (40mmoll-1). The relaxing effect of tanshinone IIA on tonic contraction of phenylephrine in isolated aortic rings without endothelium remained produced. Glibenclamide at concentration sufficient to block adenosine triphosphatase (ATP)-sensitive potassium (K+) channel attenuated this tanshinone IIA-induced relaxation that was not influenced by other inhibitors. We further investigated the effect of tanshinone IIA on the changes of intracellular calcium concentration ([Ca2+] i) in cultured aortic smooth muscle (A7r5) cells using fura-2 as indicator. Tanshinone IIA decreased [Ca2+] i elicited by phenylephrine (10nmoll(1)) or KCl (40mmoll(1)) in a concentration-dependent manner; glibenclamide, but not other inhibitors for K+ channel, abated this effect. Our results suggest that tanshinone IIA acts as an active principle of danshen showing vasodilation through ATP-sensitive K+ channel to lower [Ca2+i.

AB - Tanshinone IIA is one of the active principles in danshen (Salvia miltiorrhiza Bge) widely used in treatment of cardiovascular disorders. We investigated the effect of danshen or tanshinone IIA on blood pressure and its possible mechanisms. An i.p. injection of danshen at 10mgkg(1) significantly lowered systolic blood pressure (SBP) of spontaneously hypertensive rats (SHRs) but failed to modify the SBP in normotensive Wistar-Kyoto rats (WKY). Oral administration of tanshinone IIA also decreased SBP in SHR but not in WKY. Tanshinone IIA produced a concentration-dependent relaxation in isolated SHR aortic rings precontracted with phenylephrine (10nmol l-1) or potassium chloride (KCl) (40mmoll-1). The relaxing effect of tanshinone IIA on tonic contraction of phenylephrine in isolated aortic rings without endothelium remained produced. Glibenclamide at concentration sufficient to block adenosine triphosphatase (ATP)-sensitive potassium (K+) channel attenuated this tanshinone IIA-induced relaxation that was not influenced by other inhibitors. We further investigated the effect of tanshinone IIA on the changes of intracellular calcium concentration ([Ca2+] i) in cultured aortic smooth muscle (A7r5) cells using fura-2 as indicator. Tanshinone IIA decreased [Ca2+] i elicited by phenylephrine (10nmoll(1)) or KCl (40mmoll(1)) in a concentration-dependent manner; glibenclamide, but not other inhibitors for K+ channel, abated this effect. Our results suggest that tanshinone IIA acts as an active principle of danshen showing vasodilation through ATP-sensitive K+ channel to lower [Ca2+i.

UR - http://www.scopus.com/inward/record.url?scp=79952276155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952276155&partnerID=8YFLogxK

U2 - 10.1093/ecam/nep056

DO - 10.1093/ecam/nep056

M3 - Article

C2 - 19542183

AN - SCOPUS:79952276155

VL - 2011

JO - Evidence-based Complementary and Alternative Medicine

JF - Evidence-based Complementary and Alternative Medicine

SN - 1741-427X

M1 - 392627

ER -